ArticleJAMA network open2022

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.

Fangmeng Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.